The present invention relates to a compound of Formula (I), which are useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1. ##STR1##

 
Web www.patentalert.com

< Gene therapy for cerebrovascular disorders

< Intravenous cardiac pacing system with wireless power supply

> Method and apparatus for multiple patient parameter variability analysis and display

> Method and apparatus for detecting oscillations in cardiac rhythm
~ 00258